Goldman Sachs Group Inc Anika Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

$780 Billion
Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 64,975 shares of ANIK stock, worth $645,851. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,975

Previous 25,945 150.43%

Holding current value

$645,851

Previous $274,000 122.63%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$8.1 - $11.78 $316,143 - $459,773	39,030 Added 150.43%	64,975 $610,000
Q2 2025 Aug 14, 2025	SELL	$10.58 - $15.05 $275,492 - $391,886	-26,039 Reduced 50.09%	25,945 $274,000
Q1 2025 May 09, 2025	SELL	$15.03 - $17.97 $251,016 - $300,116	-16,701 Reduced 24.32%	51,984 $781,000
Q4 2024 Feb 11, 2025	SELL	$16.04 - $25.53 $321,473 - $511,672	-20,042 Reduced 22.59%	68,685 $1.13 Million
Q3 2024 Nov 14, 2024	BUY	$24.25 - $28.75 $336,347 - $398,762	13,870 Added 18.53%	88,727 $2.19 Million

Q2 2024 Aug 13, 2024	SELL	$24.57 - $28.47 $50,933 - $59,018	-2,073 Reduced 2.69%	74,857 $1.9 Million
Q1 2024 May 15, 2024	SELL	$21.95 - $26.42 $83,673 - $100,713	-3,812 Reduced 4.72%	76,930 $1.95 Million
Q4 2023 Feb 13, 2024	SELL	$18.47 - $23.3 $32,544 - $41,054	-1,762 Reduced 2.14%	80,742 $1.83 Million
Q3 2023 May 14, 2024	BUY	$16.98 - $26.1 $29,918 - $45,988	1,762 Added 2.18%	82,504 $1.54 Million
Q3 2023 Nov 14, 2023	BUY	$16.98 - $26.1 $377,176 - $579,759	22,213 Added 36.84%	82,504 $1.54 Million
Q2 2023 May 14, 2024	BUY	$25.16 - $28.86 $256,254 - $293,939	10,185 Added 20.33%	60,291 $1.57 Million
Q2 2023 Aug 14, 2023	BUY	$25.16 - $28.86 $256,254 - $293,939	10,185 Added 20.33%	60,291 $1.57 Million
Q1 2023 May 14, 2024	BUY	$25.91 - $32.1 $96,152 - $119,123	3,711 Added 8.0%	50,106 $1.44 Million
Q1 2023 May 11, 2023	BUY	$25.91 - $32.1 $96,152 - $119,123	3,711 Added 8.0%	50,106 $1.44 Million
Q4 2022 May 14, 2024	SELL	$23.85 - $31.91 $515,947 - $690,309	-21,633 Reduced 31.8%	46,395 $1.37 Million
Q4 2022 Feb 13, 2023	SELL	$23.85 - $31.91 $515,947 - $690,309	-21,633 Reduced 31.8%	46,395 $1.37 Million
Q3 2022 May 14, 2024	SELL	$21.74 - $24.68 $1.73 Million - $1.97 Million	-79,669 Reduced 53.94%	68,028 $1.62 Million
Q3 2022 Nov 10, 2022	SELL	$21.74 - $24.68 $1.73 Million - $1.97 Million	-79,669 Reduced 53.94%	68,028 $1.62 Million
Q2 2022 May 14, 2024	BUY	$20.4 - $25.53 $1.37 Million - $1.71 Million	66,955 Added 82.92%	147,697 $3.3 Million
Q2 2022 Aug 15, 2022	BUY	$20.4 - $25.53 $954,311 - $1.19 Million	46,780 Added 46.35%	147,697 $3.3 Million
Q1 2022 May 16, 2022	BUY	$24.7 - $36.54 $2.22 Million - $3.29 Million	90,029 Added 826.86%	100,917 $2.53 Million
Q4 2021 Feb 14, 2022	SELL	$35.83 - $45.03 $692,414 - $870,204	-19,325 Reduced 63.96%	10,888 $390,000
Q3 2021 Nov 10, 2021	BUY	$38.75 - $44.47 $1.17 Million - $1.34 Million	30,213 New	30,213 $1.29 Million

Others Institutions Holding ANIK

# of Institutions

116

Shares Held

10.7M

Call Options Held

Put Options Held

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $145M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Anika Therapeutics, Inc. Transaction History